Plans to widen access to cognitive behavioural therapy for patients with schizophrenia should be ‘reconsidered’, say researchers
They have urged the Government to reconsider current policy promoting CBT for schizophrenia, after their meta-analysis of 52 randomised controlled trials of CBT in schizophrenia conducted over the past 20 years showed little benefit.
The study, published in the latest British Journal of Psychiatry, revealed that CBT resulted in small therapeutic improvements in both positive and negative symptoms.